shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines. [electronic resource]
Producer: 20160308Description: 2300-10 p. digitalISSN:- 1936-2625
- ATP Binding Cassette Transporter, Subfamily B -- genetics
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- metabolism
- Breast Neoplasms -- chemistry
- Calcium-Binding Proteins -- genetics
- Cell Cycle Checkpoints -- drug effects
- Cell Cycle Proteins -- metabolism
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- Dose-Response Relationship, Drug
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic
- Glioma -- chemistry
- Hep G2 Cells
- Humans
- Multidrug Resistance-Associated Proteins -- genetics
- Multiple Myeloma -- drug therapy
- RNA Interference
- RNA, Small Interfering -- genetics
- Rhodamine 123 -- metabolism
- Signal Transduction -- drug effects
- Transfection
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.